DIRUI INDUSTRIAL CO.,LTD. Dirui Industrial Co.,Ltd. Stock
Equities
300396
CNE100001XS7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.49 CNY | +4.49% |
|
+0.82% | -20.24% |
| Mar. 12 | Dirui Industrial Gets Nod to Register 19 Devices | MT |
| 2023 | Dirui Industrial Co.,Ltd. Approves Election of Xiong Lingxia as Non-Employee Supervisor | CI |
| Sales 2023 * | 1.66B 229M | Sales 2024 * | 2.26B 312M | Capitalization | 6.4B 885M |
|---|---|---|---|---|---|
| Net income 2023 * | 320M 44.22M | Net income 2024 * | 438M 60.52M | EV / Sales 2023 * | 3.86 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2.83 x |
| P/E ratio 2023 * |
20.2
x | P/E ratio 2024 * |
14.8
x | Employees | 1,879 |
| Yield 2023 * |
1.89% | Yield 2024 * |
1.87% | Free-Float | 44.16% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.49% | ||
| 1 week | +0.82% | ||
| Current month | +6.68% | ||
| 1 month | -7.70% | ||
| 3 months | -15.05% | ||
| 6 months | -4.12% | ||
| Current year | -20.24% |
1 week
22.38
24.37
1 month
21.7225.50
Current year
21.7231.84
1 year
21.0138.51
3 years
13.3538.51
5 years
13.3538.51
10 years
7.8842.78
| Managers | Title | Age | Since |
|---|---|---|---|
Xue Min Wang
CEO | Chief Executive Officer | 52 | 21-09-21 |
Guo Ming Zheng
CEO | Chief Executive Officer | 41 | - |
Jie Song
FOU | Founder | 53 | 92-04-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Song
CHM | Chairman | 59 | 20-12-27 |
Jie Song
FOU | Founder | 53 | 92-04-14 |
Ge Yu
BRD | Director/Board Member | 47 | 10-07-25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 23.49 | +4.49% | 5,720,200 |
| 24-04-12 | 22.48 | -0.22% | 3,020,900 |
| 24-04-11 | 22.53 | -4.66% | 4,898,675 |
| 24-04-10 | 23.63 | -1.99% | 5,048,061 |
| 24-04-09 | 24.11 | +3.48% | 6,210,147 |
End-of-day quote Shenzhen S.E., April 14, 2024
More quotes
DIRUI INDUSTRIAL CO.,LTD is a China-based company principally engaged in the research, development, production and sale of medical testing equipment and supporting test paper and reagents. The Company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series and blood cell analysis series. The Company's products are used for routine physical examination and diagnosis of illness. The Company distributes its products in domestic market and to overseas markets.
Calendar
2024-04-18
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
23.49
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.24% | 847M | |
| +4.57% | 13.15B | |
| -15.79% | 7.14B | |
| -6.11% | 4.92B | |
| -5.70% | 4.34B | |
| -2.82% | 4.17B | |
| -41.28% | 4.12B | |
| +7.49% | 2.6B | |
| -1.90% | 2.36B | |
| +0.16% | 1.76B |
- Stock Market
- Equities
- 300396 Stock
